TrueMed is interested in partnering for innovative specialty and rare disease therapeutics, that will complement our portfolio and fit our expertise and capabilities. We focus on therapies in commercial or late clinical stage, but we would consider earlier stage commitment if relevant.
An ideal partner for us would be a small to mid-size company that shares our passion for patient care, with therapies that address an unmet medical need or provide a significant improvement over current standard of care in the relevant therapeutic space.
We evaluate each therapy to ensure that we can make a real impact based on the local opportunity and our ability to optimize it. The TrueMed team has deep industry experience in various specialties, long-term relationships with key decision makers, and a commitment to results.
TrueMed’s team, infrastructure, and market position allow us to show results quickly, while building a solid foundation to ensure long-term growth for our partners.